Advertisement
UK markets open in 6 hours 17 minutes

  • NIKKEI 225

    38,253.29
    +701.13 (+1.87%)
     

  • HANG SENG

    16,828.93
    +317.24 (+1.92%)
     

  • CRUDE OIL

    83.46
    +0.10 (+0.12%)
     

  • GOLD FUTURES

    2,336.10
    -6.00 (-0.26%)
     

  • DOW

    38,503.69
    +263.71 (+0.69%)
     

  • Bitcoin GBP

    53,472.16
    -272.98 (-0.51%)
     

  • CMC Crypto 200

    1,430.12
    +15.36 (+1.09%)
     

  • NASDAQ Composite

    15,696.64
    +245.33 (+1.59%)
     

  • UK FTSE All Share

    4,378.75
    +16.15 (+0.37%)
     
Money:

What is the true cost of the UK state pension?

To get a sense of the true value of the state pension, you can look at how much you would need to save to match it yourself

ELV or PGNY: Which Is the Better Value Stock Right Now?

Zacks Equity Research
·2-min read

Investors looking for stocks in the Medical Services sector might want to consider either Elevance Health (ELV) or Progyny (PGNY). But which of these two stocks offers value investors a better bang for their buck right now? We'll need to take a closer look.

We have found that the best way to discover great value opportunities is to pair a strong Zacks Rank with a great grade in the Value category of our Style Scores system. The proven Zacks Rank puts an emphasis on earnings estimates and estimate revisions, while our Style Scores work to identify stocks with specific traits.

Elevance Health and Progyny are both sporting a Zacks Rank of # 2 (Buy) right now. This system places an emphasis on companies that have seen positive earnings estimate revisions, so investors should feel comfortable knowing that these stocks have improving earnings outlooks. But this is only part of the picture for value investors.

Value investors also tend to look at a number of traditional, tried-and-true figures to help them find stocks that they believe are undervalued at their current share price levels.

ADVERTISEMENT

Our Value category grades stocks based on a number of key metrics, including the tried-and-true P/E ratio, the P/S ratio, earnings yield, and cash flow per share, as well as a variety of other fundamentals that value investors frequently use.

ELV currently has a forward P/E ratio of 17.99, while PGNY has a forward P/E of 147.69. We also note that ELV has a PEG ratio of 1.50. This popular metric is similar to the widely-known P/E ratio, with the difference being that the PEG ratio also takes into account the company's expected earnings growth rate. PGNY currently has a PEG ratio of 7.01.

Another notable valuation metric for ELV is its P/B ratio of 3.48. The P/B ratio is used to compare a stock's market value with its book value, which is defined as total assets minus total liabilities. For comparison, PGNY has a P/B of 10.

These are just a few of the metrics contributing to ELV's Value grade of A and PGNY's Value grade of D.

Both ELV and PGNY are impressive stocks with solid earnings outlooks, but based on these valuation figures, we feel that ELV is the superior value option right now.


Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
 
Elevance Health, Inc. (ELV) : Free Stock Analysis Report
 
Progyny, Inc. (PGNY) : Free Stock Analysis Report
 
To read this article on Zacks.com click here.
 
Zacks Investment Research